Rapid Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 in Detention Facility, Louisiana, USA, May-June, 2020.
Adult
COVID-19
/ diagnosis
COVID-19 Testing
/ statistics & numerical data
Disease Outbreaks
/ statistics & numerical data
Disease Transmission, Infectious
/ statistics & numerical data
Female
Humans
Incidence
Louisiana
/ epidemiology
Male
Prisons
Prospective Studies
SARS-CoV-2
/ isolation & purification
COVID-19
Louisiana
SARS-CoV-2
United States
coronavirus disease
coronaviruses
correctional facilities
detention facilities
respiratory infections
serial testing
severe acute respiratory syndrome coronavirus 2
transmission
viruses
zoonoses
Journal
Emerging infectious diseases
ISSN: 1080-6059
Titre abrégé: Emerg Infect Dis
Pays: United States
ID NLM: 9508155
Informations de publication
Date de publication:
Feb 2021
Feb 2021
Historique:
pubmed:
5
1
2021
medline:
3
2
2021
entrez:
4
1
2021
Statut:
ppublish
Résumé
To assess transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in a detention facility experiencing a coronavirus disease outbreak and evaluate testing strategies, we conducted a prospective cohort investigation in a facility in Louisiana, USA. We conducted SARS-CoV-2 testing for detained persons in 6 quarantined dormitories at various time points. Of 143 persons, 53 were positive at the initial test, and an additional 58 persons were positive at later time points (cumulative incidence 78%). In 1 dormitory, all 45 detained persons initially were negative; 18 days later, 40 (89%) were positive. Among persons who were SARS-CoV-2 positive, 47% (52/111) were asymptomatic at the time of specimen collection; 14 had replication-competent virus isolated. Serial SARS-CoV-2 testing might help interrupt transmission through medical isolation and quarantine. Testing in correctional and detention facilities will be most effective when initiated early in an outbreak, inclusive of all exposed persons, and paired with infection prevention and control.
Identifiants
pubmed: 33395380
doi: 10.3201/eid2702.204158
pmc: PMC7853536
doi:
Types de publication
Evaluation Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
421-429Références
MMWR Morb Mortal Wkly Rep. 2020 May 15;69(19):594-598
pubmed: 32407301
Emerg Infect Dis. 2020 Jul;26(7):
pubmed: 32364890
MMWR Morb Mortal Wkly Rep. 2020 Jul 03;69(26):836-840
pubmed: 32614816
MMWR Morb Mortal Wkly Rep. 2020 Aug 21;69(33):1139-1143
pubmed: 32817597
Lancet Infect Dis. 2020 Jun;20(6):656-657
pubmed: 32199493
Bioinformatics. 2018 Dec 1;34(23):4121-4123
pubmed: 29790939
Emerg Infect Dis. 2020 Jun;26(6):1266-1273
pubmed: 32160149
Emerg Infect Dis. 2020 Aug;26(8):
pubmed: 32396505
MMWR Morb Mortal Wkly Rep. 2020 May 29;69(21):651-655
pubmed: 32463809
Clin Infect Dis. 2007 Oct 15;45(8):1047-55
pubmed: 17879924
MMWR Morb Mortal Wkly Rep. 2020 May 01;69(17):523-526
pubmed: 32352954
N Engl J Med. 2020 May 28;382(22):2081-2090
pubmed: 32329971
JAMA Intern Med. 2020 Aug 1;180(8):1041-1042
pubmed: 32343355
MMWR Morb Mortal Wkly Rep. 2020 Aug 11;69(32):1095-1099
pubmed: 32790655
Emerg Infect Dis. 2020 Oct;26(10):2401-2405
pubmed: 32610037
JAMA. 2020 Jun 9;323(22):2249-2251
pubmed: 32374370
BMJ. 2020 Apr 21;369:m1443
pubmed: 32317267
JAMA. 2020 Aug 11;324(6):602-603
pubmed: 32639537
Clin Infect Dis. 2020 Jun 21;:
pubmed: 32562541
MMWR Morb Mortal Wkly Rep. 2020 Jul 31;69(30):993-998
pubmed: 32730238